Novocure Ltd - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NVCR Nasdaq 2836 https://www.novocure.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novocure Ltd

Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China - Nov 14th, 2018 5:30 am
Zai Lab and Novocure Awarded Deal of the Year - Nov 14th, 2018 5:30 am
3 Top Healthcare Stocks to Buy in November - Nov 13th, 2018 6:01 pm
Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology - Nov 13th, 2018 6:24 am
Novocure and Zai Lab to Host Investor Event - Nov 7th, 2018 2:00 pm
NovoCure Limited (NASDAQ:NVCR): Is Breakeven Near? - Nov 7th, 2018 10:25 am
Here's Why NovoCure Fell 36.8% in October - Nov 7th, 2018 9:22 am
Edited Transcript of NVCR earnings conference call or presentation 25-Oct-18 12:00pm GMT - Oct 30th, 2018 12:04 pm
New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure — Consolidated Revenues, Company Growth, and Expectations for 2018 - Oct 30th, 2018 5:30 am
Here's Why Novocure Is Tumbling Today - Oct 25th, 2018 1:11 pm
NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates - Oct 25th, 2018 7:05 am
Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update - Oct 25th, 2018 4:00 am
Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors - Oct 24th, 2018 2:00 pm
Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma - Oct 23rd, 2018 3:57 pm
Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields - Oct 22nd, 2018 5:30 am
Gauging Analysts’ Views for NovoCure Stock - Oct 19th, 2018 8:32 am
NovoCure’s Operational Performance in Q3 2018: What to Expect - Oct 19th, 2018 7:02 am
NovoCure: Its Top-Line Forecast for Q3 2018 - Oct 19th, 2018 6:24 am
NovoCure (NVCR) Q3 Earnings Preview: What to Look Out For - Oct 18th, 2018 8:33 am
Novocure Announces that the Medicare DME MACs Have Accepted the Local Coverage Determination Reconsideration Request for Optune® - Oct 18th, 2018 5:30 am